- Third consensus on medical treatment of metastatic breast cancer2009 | First Faculty of Medicine
- Metastatic treatment of breast cancer in the light of new possibilities for chemotherapy, hormonal therapy and biotherapyPublication without faculty affiliation
- New treatment options for HER2-dependent metastatic breast cancer2011 | First Faculty of Medicine
- Metastatic Breast Cancer as a Rare Cause of Deafness and Eyesight Deterioration: Case Report2019 | First Faculty of Medicine, Third Faculty of Medicine
- Lapatinib and the treatment of metastatic breast cancer treated by trastuzumab2009 | First Faculty of Medicine
- Complete and long-term response of HER2 positive locally highly advanced metastatic breast cancer - case report2019 | Third Faculty of Medicine
- Quality of life and depression among metastatic breast cancer patients2010 | Faculty of Medicine in Hradec Králové
- Trastuzumab deruxtecan in the treatment of patients with metastatic HER2‑low breast cancer2023 | First Faculty of Medicine
- Biological therapy for breast cancer2009 | First Faculty of Medicine
- Eskalace a deeskalace léčby pacientek s karcinomem prsu v roce 20212022 | First Faculty of Medicine
- Karcinom prsu - současnost a novinky v léčbě2016 | First Faculty of Medicine
- Usage of eribulin and vinorelbine in the treatment of breast cancer - two case reports2019 | First Faculty of Medicine
- Aktuální možnosti léčby metastazujícího triple negativního karcinomu prsu2022 | First Faculty of Medicine
- Predictive markers in breast cancer2021 | First Faculty of Medicine